|
π¬
|
Neuropilin Is a Semaphorin III Receptor
A. Kolodkin,
Dorothy V Levengood,
E. G. Rowe,
Y. Tai,
R. Giger,
D. Ginty
|
10 |
1997 |
10
π¬
|
|
π
|
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.
17 auth.
F. Davies,
N. Raje,
T. Hideshima,
S. Lentzsch,
G. Young,
Y. Tai,
B. Lin,
K. Podar,
Deepak K. Gupta,
D. Chauhan,
...
S. Treon,
P. Richardson,
R. Schlossman,
G. Morgan,
G. Muller,
D. Stirling,
K. Anderson
|
9 |
2001 |
9
π
|
|
π
|
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.
13 auth.
T. Hideshima,
D. Chauhan,
Y. Shima,
N. Raje,
F. Davies,
Y. Tai,
S. Treon,
B. Lin,
R. Schlossman,
P. Richardson,
...
G. Muller,
D. Stirling,
K. Anderson
|
9 |
2000 |
9
π
|
|
π
|
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
16 auth.
M. de Weers,
Y. Tai,
M. S. van der Veer,
J. Bakker,
T. Vink,
D. Jacobs,
L. Oomen,
M. Peipp,
T. Valerius,
J. Slootstra,
...
T. Mutis,
W. Bleeker,
K. Anderson,
H. Lokhorst,
J. V. D. van de Winkel,
P. Parren
|
9 |
2011 |
9
π
|
|
π
|
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
35 auth.
N. Bolli,
H. Avet-Loiseau,
D. Wedge,
P. Van Loo,
L. Alexandrov,
I. Martincorena,
K. Dawson,
F. Iorio,
S. Nik-Zainal,
G. Bignell,
Jonathan Hinton,
Yilong Li,
J. TubΓo,
Stuart Mclaren,
Sarah O 'meara,
...
Adam P. Butler,
J. Teague,
L. Mudie,
Elizabeth Anderson,
N. Rashid,
Y. Tai,
M. Shammas,
A. Sperling,
M. Fulciniti,
P. Richardson,
G. Parmigiani,
F. Magrangeas,
S. Minvielle,
P. Moreau,
M. Attal,
T. Facon,
P. Futreal,
K. Anderson,
Peter J. Campbell,
Nikhil C. Munshi
|
9 |
2014 |
9
π
|
|
π
|
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.
15 auth.
N. Mitsiades,
C. Mitsiades,
P. Richardson,
V. Poulaki,
Y. Tai,
D. Chauhan,
G. Fanourakis,
Xuesong Gu,
Charles Bailey,
Marie G. Joseph,
...
T. Libermann,
R. Schlossman,
N. Munshi,
T. Hideshima,
K. Anderson
|
9 |
2003 |
9
π
|
|
π
|
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.
13 auth.
A. Roccaro,
A. Sacco,
P. Maiso,
A. Azab,
Y. Tai,
M. Reagan,
F. Azab,
L. Flores,
F. Campigotto,
E. Weller,
...
K. Anderson,
D. Scadden,
I. Ghobrial
|
9 |
2013 |
9
π
|
|
π
|
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
64 auth.
C. Bellodi,
M. Lidonnici,
A. Hamilton,
G. Helgason,
A. R. Soliera,
M. Ronchetti,
S. Galavotti,
K. W. Young,
Tommaso Selmi,
R. Yacobi,
R. A. Etten,
N. Donato,
A. Hunter,
D. Dinsdale,
E. TirrΓ²,
...
P. Vigneri,
P. Nicotera,
M. Dyer,
T. Holyoake,
P. Salomoni,
K. Funai,
Haowei Song,
L. Yin,
I. Lodhi,
Xiaochao Wei,
J. Yoshino,
T. Coleman,
C. Semenkovich,
Aldo M. Roccaro,
A. Sacco,
P. Maiso,
A. Azab,
Y. Tai,
M. Reagan,
F. Azab,
L. Flores,
F. Campigotto,
E. Weller,
K. Anderson,
D. Scadden,
I. Ghobrial,
S. Ramachandrappa,
Anne Raimondo,
A. CaliΜ,
J. Keogh,
E. Henning,
Sadia Saeed,
A. Thompson,
Sumedha Garg,
Elena G. Bochukova,
S. Brage,
Victoria Trowse,
E. Wheeler,
Adrienne E. Sullivan,
M. Dattani,
Peter E. Clayton,
V. Datta,
J. Bruning,
N. Wareham,
S. OβRahilly,
D. Peet,
I. Barroso,
M. Whitelaw,
S. Farooqi
|
9 |
2009 |
9
π
|
|
π
|
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
21 auth.
T. Chonghaile,
K. Sarosiek,
Thanh-Trang T. Vo,
J. Ryan,
Anupama Tammareddi,
V. Moore,
Jing Deng,
K. Anderson,
P. Richardson,
Y. Tai,
...
C. Mitsiades,
U. Matulonis,
R. Drapkin,
R. Stone,
D. DeAngelo,
D. McConkey,
S. Sallan,
L. Silverman,
M. Hirsch,
D. Carrasco,
A. Letai
|
9 |
2011 |
9
π
|
|
π
|
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
18 auth.
Deepak K. Gupta,
S. Treon,
Y. Shima,
T. Hideshima,
K. Podar,
Y. Tai,
B. Lin,
S. Lentzsch,
F. Davies,
D. Chauhan,
...
R. Schlossman,
P. Richardson,
P. Ralph,
Lei Wu,
F. Payvandi,
G. Muller,
D. Stirling,
K. Anderson
|
9 |
2001 |
9
π
|
|
π
|
Somatic mutations of the histone H3K27 demethylase, UTX, in human cancer
63 auth.
G. van Haaften,
G. Dalgliesh,
Helen R Davies,
Lina Chen,
G. Bignell,
C. Greenman,
S. Edkins,
Claire W. Hardy,
S. OβMeara,
J. Teague,
A. Butler,
Jonathan Hinton,
Calli Latimer,
J. Andrews,
S. Barthorpe,
...
D. Beare,
G. Buck,
P. Campbell,
J. Cole,
R. Dunmore,
S. Forbes,
Mingming Jia,
David Jones,
C. Kok,
Catherine Leroy,
MengβLay Lin,
D. Mcbride,
M. Maddison,
S. Maquire,
K. McLay,
A. Menzies,
T. Mironenko,
Mulderrig Lee,
L. Mudie,
E. Pleasance,
Rebecca Shepherd,
Raffaella Smith,
L. Stebbings,
P. Stephens,
Gurpreet W. Tang,
P. Tarpey,
Rachel Turner,
K. Turrell,
J. Varian,
S. West,
S. Widaa,
P. Wray,
V. Collins,
K. Ichimura,
S. Law,
J. Wong,
S. Yuen,
S. Leung,
G. Tonon,
R. DePinho,
Y. Tai,
K. Anderson,
R. Kahnoski,
A. Massie,
S. Khoo,
B. Teh,
M. Stratton,
P. Futreal
|
9 |
2009 |
9
π
|
|
π¦
|
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.
22 auth.
Y. Tai,
M. Dillon,
Weihua Song,
M. Leiba,
Xian-Feng Li,
P. Burger,
A. I. Lee,
K. Podar,
T. Hideshima,
A. Rice,
...
Anne van Abbema,
L. Jesaitis,
I. Caras,
D. Law,
E. Weller,
W. Xie,
P. Richardson,
N. Munshi,
C. Mathiot,
H. Avet-Loiseau,
D. Afar,
K. Anderson
|
8 |
2008 |
8
π¦
|
|
π
|
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration.
14 auth.
K. Podar,
Y. Tai,
F. Davies,
S. Lentzsch,
M. Sattler,
T. Hideshima,
B. Lin,
Deepak K. Gupta,
Yoshihito Shima,
D. Chauhan,
...
C. Mitsiades,
N. Raje,
P. Richardson,
K. Anderson
|
8 |
2001 |
8
π
|
